'We are currently discussing with the Indian government an expedited approval pathway to make our Pfizer-BioNTech vaccine available for use in the country,' says Pfizer CEO in a LinkedIn post
Global pharma major Pfizer is sending its medicines worth USD 70 million from its distribution centres in the US, Europe and Asia
Protection against coronavirus seen from about 14 days after vaccination
Govt should remove uncertainty about next phase of vaccination
With millions of lives at stake amid a rapid spread of Covid-19, Indian-American Congressman Ro Khanna said he hoped President Joe Biden would call the Pfizer CEO to let India produce its vaccine
The Russian vaccine has six times lower infection rate than Pfizer's
Two govt officials said New Delhi is now leaving it up to states, companies to sign deals with foreign drugmakers while it buys in bulk most of the output of local producers - SII and Bharat Biotech
A single dose of either the Oxford/AstraZeneca or Pfizer/BioNTech vaccines, currently being administered in the UK, cut the rate of coronavirus infections by around 65%
At a patisserie in the small town of Veresegyhaz, the choice is between a selection of layered mousses with colourful jelly toppings, presented in small glasses, with decorative syringes on top
States allowed to procure directly from manufacturers; open market supply permitted
Some good moves but freer pricing needed
Of this list, Sputnik V is already approved in India and Sinovac is unlikely to come in as it does not meet the aforementioned criteria
Pfizer Chief Executive Officer Albert Bourla said people will likely need a third dose of the Pfizer/BioNTech Covid-19 vaccine within 12 months of getting fully inoculated
Many vaccine makers in talks with govt as India wants a portfolio of products
No need for prior local clinical trials for vaccines cleared by regulators
Fast-tracking of vaccine approvals is a welcome policy change
The deciding factor in days to come has to be the financial space
Pfizer and BioNTech have asked the US Food and Drug Administration (FDA) to expand the Emergency Use Authorization (EUA) for its Covid-19 vaccine to include children ages 12 to 15.
Drug giant Pfizer and its partner in developing the first COVID-19 vaccine that received emergency authorisation in the US want to allow more adolescents to receive the vaccine
Australia's Chief Medical Officer, Paul Kelly, told reporters the risk of clots was extremely low.